Condition: Anemia · Iron Deficiency Anemia (IDA) · Sponsor: Pharmanutra S.p.a.
This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence. Participants will be randomly assigned to receive either Sucrosomial® Iron or Ferric Maltol for 12 weeks. The primary objective is to determine whether Sucrosomial® Iron is as effective as Ferric Maltol in normalizing hemoglobin levels.
This description comes directly from the study's public registry record.
Maria Sole Rossato · +390507846500 · ms.rossato@pharmanutra.it
Nataliya Pylypiv · +390507846598 · n.pylypiv@pharmanutra.it
Always discuss trial participation with your own doctor first.
| Hospital Quironsalud Barcelona | Barcelona, Spain | Recruiting |
| Hospital Universitari Dexeus Grupo Quironsalud | Barcelona, Spain | Recruiting |
| Hospital Universitari Sagrat Cor | Barcelona, Spain | Recruiting |
| Hospital Quironsalud Malaga | Málaga, Spain | Recruiting |
| Hospital Quironsalud Malága | Málaga, Spain | Recruiting |
| Hospital Universitari General De Catalunya | Sant Cugat del Vallès, Spain | Recruiting |
| Hospital Quironsalud Zaragoza | Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07308769